Rifampin-Resistant Cutibacterium (formerly Propionibacterium) namnetense Superinfection after Staphylococcus aureus Bone Infection Treatment
| Autor: | S. Corvec, A. Guillouzouic, G. G. Aubin, S. Touchais, O. Grossi, F. Gouin, P. Bémer |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Staphylococcus aureus Short Communication 030106 microbiology medicine.disease_cause Microbiology Bone Infection resistance 03 medical and health sciences lcsh:Orthopedic surgery In vivo Levofloxacin medicine polycyclic compounds bone infection Orthopedics and Sports Medicine Pyogenic granuloma business.industry biochemical phenomena metabolism and nutrition medicine.disease rpoB [Propionibacterium] namnetense lcsh:RD701-811 030104 developmental biology Infectious Diseases Cutibacterium namnetense Superinfection Surgery business rifampin medicine.drug |
| Zdroj: | Journal of Bone and Joint Infection Journal of Bone and Joint Infection, Vol 3, Pp 255-257 (2018) |
| ISSN: | 2206-3552 |
| Popis: | After rifampin and levofloxacin treatment for a Staphylococcus aureus bone infection, a pyogenic granuloma due to a newly described Cutibacterium species, C. namnetense developed on the tibia former external fixator. This rifampin resistant bacterium, selected during treatment, harbored a mutation in the rpoB gene. This case illustrates the possible in vivo selection of resistant mutant most likely due to the bacterial burden and therefore the importance of adequate bone infection treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|